ERBB2 and breast carcinoma: We also established a 4-gene score based on genes differentially expressed between the parental and lung metastasis cell lines that predicts neoadjuvant chemotherapy (NAC) response in ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer [24].